Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI, and CDAI scores and to reveal the immunological...

Full description

Bibliographic Details
Main Authors:	Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2012-06-01
Series:	Научно-практическая ревматология
Subjects:	das 28 cdai m a rheumatoid arthritis tocilizumab sdai erythrocyte sedimentation rate c-reactive protein igm/iga rheumatoid factors anti-cyclic citrullinated peptide antibodies anti-modified citrullinated vimentin antibodies immunoglobulins g
Online Access:	https://rsp.mediar-press.net/rsp/article/view/842

Similar Items

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
by: A S Avdeeva, et al.
Published: (2013-05-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city
by: Banaz Abdulsattar Hamad, et al.
Published: (2017-08-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation
by: B Siddhartha Kumar, et al.
Published: (2017-01-01)

Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
by: Vladimira Boyadzhieva, et al.
Published: (2018-11-01)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
by: Somayye Norouzi, et al.
Published: (2020-08-01)

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis
by: Brian C. Sauer, et al.
Published: (2020-10-01)

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
by: Ishigooka, Nozomi
Published: (2020)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013-03-01)

Influence of Ambient Air Pollution on Rheumatoid Arthritis Disease Activity Score Index
by: Ahmad Alsaber, et al.
Published: (2020-01-01)

Methotrexate-induced changes in the concentration of antibodies to modified citrulnated vimentin in blood serum of patients with rheumatoid arthritis
by: Natal'ya Petrovna Shilkina, et al.
Published: (2011-05-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
by: Bambang Setyohadi, et al.
Published: (2018-06-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
by: Ilaria Fanelli, et al.
Published: (2021-07-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
by: Pit Hui Lew, et al.
Published: (2021-07-01)

Detection and clinical significance of rheumatoid factor, anti -CCP antibody , immunoglobulin and cytokines in serum of patients with rheumatoid arthritis
by: Hui-Ya Zhu, et al.
Published: (2016-12-01)

Determinação de citocinas da via TH17 e da atividade imunomoduladora do novo derivado Tiazolidínico LPSF/TM17, agonista do PPARy, em células do sangue periférico de pacientes portadores de artrite reumatoide
by: ROCHA JÚNIOR, Laurindo Ferreira da
Published: (2016)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-01-01)

Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
by: Chao-Yi Wu, et al.
Published: (2020-06-01)

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
by: AlOmair M, et al.
Published: (2021-08-01)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
by: Mahmood NMA, et al.
Published: (2018-08-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)